当前位置:首页 - 行情中心 - 可孚医疗(301087) - 财务分析

可孚医疗

(301087)

  

流通市值:107.65亿  总市值:115.90亿
流通股本:1.94亿   总股本:2.09亿

可孚医疗(301087)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年年度实现净利润3.70亿元,每股收益1.83元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年年度最新股东权益490288.85万元,未分配利润76974.53万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年年度最新总资产662891.52万元,负债172602.67万元。

利润表
报告期2025-12-312025-09-302025-06-302025-03-31
营业总收入3,387,499,253.242,397,791,920.731,495,764,000.12737,792,254.37
营业总成本3,038,805,623.012,140,937,840.581,324,393,499.85646,327,861.69
其他经营收益
营业利润429,044,340.65301,810,929.65197,076,115.25109,667,821.89
利润总额425,842,807.11304,177,103.13199,658,996.39109,426,701.27
净利润370,316,214.99259,507,645.73166,642,911.691,572,859.16
每股收益
其他综合收益-1,767,715.86643,588.1--
综合收益总额368,548,499.13260,151,233.83166,642,911.691,572,859.16
资产负债表
报告期2025-12-312025-09-302025-06-302025-03-31
流动资产:
流动资产合计3,835,321,664.483,894,095,362.253,764,999,620.853,913,564,439.07
非流动资产:
非流动资产合计2,793,593,565.552,646,196,983.252,583,062,050.132,504,769,103.77
资产总计6,628,915,230.036,540,292,345.56,348,061,670.986,418,333,542.84
流动负债:
流动负债合计1,588,765,842.511,637,988,672.11,419,124,954.681,355,621,458.83
非流动负债:
非流动负债合计137,260,900.1151,810,702.44154,512,523.24153,996,075
负债合计1,726,026,742.611,789,799,374.541,573,637,477.921,509,617,533.83
所有者权益(或股东权益):
归属于母公司股东权益合计4,866,857,736.114,713,657,384.444,737,676,805.624,893,677,663.77
股东权益合计4,902,888,487.424,750,492,970.964,774,424,193.064,908,716,009.01
负债和股东权益合计6,628,915,230.036,540,292,345.56,348,061,670.986,418,333,542.84
现金流量表
报告期2025-12-312025-09-302025-06-302025-03-31
经营活动产生的现金流量:
经营活动现金流入小计3,779,567,063.092,636,305,027.871,633,833,084.46791,876,819.3
经营活动现金流出小计3,083,841,246.382,046,313,639.681,282,399,646.74681,818,542.11
经营活动产生的现金流量净额695,725,816.71589,991,388.19351,433,437.72110,058,277.19
投资活动产生的现金流量:
投资活动现金流入小计2,288,300,077.521,311,720,780.841,191,807,578.5568,698,795.13
投资活动现金流出小计2,357,260,147.761,477,933,054.821,145,094,643.56163,604,201.84
投资活动产生的现金流量净额-68,960,070.24-166,212,273.9846,712,934.99-94,905,406.71
筹资活动产生的现金流量:
筹资活动现金流入小计1,246,432,050.11,136,639,341.57597,133,829.84439,085,657.3
筹资活动现金流出小计1,715,178,834.641,486,487,292.43992,524,915.49543,366,028.24
筹资活动产生的现金流量净额-468,746,784.54-349,847,950.86-395,391,085.65-104,280,370.94
汇率变动对现金及现金等价物的影响-3,429,799.77-2,049,743.68-543,325.85-1,034.91
现金及现金等价物净增加额154,589,162.1671,881,419.672,211,961.21-89,128,535.37
期末现金及现金等价物余额1,294,575,300.71,211,867,558.211,142,198,099.751,050,857,603.17
补充资料:
现金及现金等价物的净增加额154,589,162.16-2,211,961.21-
最新报告期:2026-03-10
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中泰证券祝嘉琦,谢木青2.212.803.432026-03-10
开源证券余汝意,石启正2.232.673.272026-03-10
财信证券龙靖宁2.212.713.212026-03-10
TOP↑